News Focus
News Focus
icon url

DewDiligence

07/25/18 5:14 PM

#220199 RE: DewDiligence #220198

GILD 2Q18 HCV sales—$542M US/$458M ex-US (see slide #25).
icon url

DewDiligence

10/25/18 5:04 PM

#221624 RE: DewDiligence #220198

GILD 3Q18 results—HCV sales=$902M,-10% QoQ:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2373553

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDEyNDE4fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636759229545616779

3Q18 US HCV sales were $487M, -10% QoQ; 3Q18 ex-US HCV sales were $415M, -10% QoQ (see slide #25).